Flow cytometric analysis of the ERCC1, marker of DNA damage repair, in the tumor specimens embedded into paraffin blocks.

Autor: Bogush TA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia. tatbogush@mail.ru., Dudko EA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Grishanina AN; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Zarkua VT; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Bogush EA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Basharina AA; Faculty of Fundamental Medicine, Moscow State University, Moscow, 1192324, Russia., Polotsky BE; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Tjulandin SA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Davydov MM; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Davydov MI; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia.

Publikováno v: Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2017 Jan; Vol. 472 (1), pp. 9-11. Date of Electronic Publication: 2017 Apr 19.

Digoxin is a selective modifier increasing platinum drug anticancer activity.

Autor: Bogush TA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Kashirskoe sh. 24, Moscow, 115478, Russia. tatbogush@mail.ru., Chernov VY; Faculty of Biology, Lomonosov Moscow State University, Moscow, 119991, Russia., Dudko EA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Kashirskoe sh. 24, Moscow, 115478, Russia., Shprakh ZS; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Kashirskoe sh. 24, Moscow, 115478, Russia., Bogush EA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Kashirskoe sh. 24, Moscow, 115478, Russia., Polotsky BE; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Kashirskoe sh. 24, Moscow, 115478, Russia., Tjulandin SA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Kashirskoe sh. 24, Moscow, 115478, Russia., Davydov MI; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Kashirskoe sh. 24, Moscow, 115478, Russia.

Publikováno v: Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2016 May; Vol. 468 (1), pp. 220-3. Date of Electronic Publication: 2016 Jul 15.

[ERCC1 as a Marker of Ovarian Cancer Resistance to Platinum Drugs].

Autor: Bogush TA, Popova AS, Dudko EA, Bogush EA, Tyulyandina AS, Tyulyandin SA, Davydov MI

Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] [Antibiot Khimioter] 2015; Vol. 60 (3-4), pp. 42-50.

Immunofluorescent assay of ERCC1 and estimation of clinical significance of the protein expression in ovarian cancer tissue.

Autor: Bogush TA; Blokhin Cancer Research Center, Russian Academy of Medical Science, Kashirskoe sh. 24, Moscow, 115478, Russia, bogush@orc.ru., Dudko EA, Semakov AV, Bogush EA, Tjulandina AS, Zarkua VT, Tjulandin SA, Davydov MI

Publikováno v: Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2014; Vol. 457, pp. 141-5. Date of Electronic Publication: 2014 Aug 30.

[Expression of estrogen receptors beta and beta1 in tissue of human non-small cell lung cancer].

Autor: Shaturova AS, Bogush TA, Dudko EA, Chemeris GIu, Ramanauskaĭte RIu, Kalganov ID

Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] [Antibiot Khimioter] 2012; Vol. 57 (5-6), pp. 11-7.